|
Real-time Estimate
Cboe BZX
20:17:59 22/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.365 USD | +19.74% |
|
+21.24% | -41.20% |
| 08-13 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-13 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +19.74% | +21.24% | +12.76% | -38.01% | -41.20% | -32.51% | +13.22% | -92.89% | - | 66.39M | |
| -0.07% | +5.66% | +3.06% | +63.41% | +85.18% | +54.34% | +113.69% | +10.14% | - | 74.33B | |
| -1.45% | -0.40% | -1.02% | +7.46% | +19.34% | +35.52% | +79.18% | +217.76% | +5,564.90% | 62.26B | |
| -0.66% | +7.14% | +3.24% | +70.83% | +67.46% | +39.36% | +29.20% | -56.67% | - | 27.72B | |
| -1.13% | +0.16% | -3.12% | +21.81% | -30.98% | -17.18% | +358.98% | +350.37% | +700.77% | 26.42B | |
| +1.99% | +4.38% | -10.54% | +11.90% | +6.01% | +2.23% | -3.55% | -70.25% | - | 24.62B | |
| +0.84% | +6.00% | +7.91% | +37.66% | +12.43% | +25.53% | -9.89% | -18.55% | +98.87% | 20.72B | |
| +0.87% | -2.52% | -17.14% | +21.39% | +173.78% | +151.81% | +328.17% | +1,384.37% | +645.67% | 15.01B | |
| +2.57% | +3.06% | +7.50% | +14.20% | +33.79% | +48.16% | +173.00% | +190.30% | +297.83% | 14.18B | |
| +1.18% | -1.21% | +35.04% | +20.38% | -1.72% | -10.00% | +819.25% | +231.85% | +99.88% | 13.48B | |
| -1.09% | +1.87% | -8.88% | +17.89% | +24.99% | -3.79% | +513.52% | - | - | 15.1B | |
| +0.12% | -0.02% | +2.18% | +2.00% | -10.16% | +18.88% | +241.17% | +565.17% | +4,425.56% | 12.06B | |
| -3.42% | +0.21% | +6.26% | +9.54% | -15.13% | -26.06% | +162.74% | +129.43% | - | 11.66B | |
| +1.33% | -1.05% | -11.03% | -13.37% | +7.94% | +42.15% | +121.60% | +102.67% | +676.73% | 9.39B | |
| +4.06% | +1.09% | -17.63% | -12.88% | +7.61% | +122.90% | +162.26% | +13.85% | +882.67% | 9.72B | |
| +5.74% | +9.15% | +17.22% | +23.06% | +348.74% | +232.77% | +438.48% | -12.20% | - | 8.96B | |
| +0.13% | -0.06% | -4.36% | +13.56% | +28.25% | +76.80% | +12.82% | +127.42% | - | 8.77B | |
| -1.12% | +4.41% | +0.57% | +15.84% | +10.21% | -23.63% | +106.91% | -22.66% | - | 8.73B | |
| -0.99% | +0.33% | -14.44% | -9.04% | +178.54% | +496.80% | +669.39% | -52.16% | -43.15% | 8.11B | |
| +1.27% | +4.17% | +11.10% | +20.01% | +10.34% | +147.58% | +460.32% | - | - | 6.98B | |
| Average | +1.47% | -0.22% | +0.93% | +14.88% | +45.77% | +69.08% | +239.52% | +166.55% | +1,334.97% | 18.91B | |
| Weighted average by Cap. | +0.06% | +1.29% | +0.45% | +27.15% | +45.63% | +51.20% | +186.91% | +158.03% | +2,352.92% |
- Stock Market
- Stocks
- SPRO Stock
- Sector Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
